Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.369ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
C.30ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
W.3ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
B.1.177.67ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
BA.2.3ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
B.1.407ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
BA.3 (Omicron)ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
BA.3.1ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
AY.87 (Delta)ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
AY.102 (Delta)ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
D.4ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
B.1.562ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
C.30.1ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17929.7Japan
HV.1.7SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-17934.7South Korea
B.1.617.2 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-17940.7Thailand
B.1.471NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-17944.4US
B.1.1.421NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-17944.4US
B.1.177.67NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-17944.4US
BL.1.5NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
BA.2.38.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
BA.2.25.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
BA.2.3.7NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
B.1.545NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
EG.2.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
XBB.1.9.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
B.1.340NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
B.1.1.74NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
B.1.1.463NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
N.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
BA.1.17.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
P.1.9 (Gamma)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
B.1.1.239NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
FD.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
B.1.1.297NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17951.7China
B.50ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-17963.7Japan
BQ.1.1.58ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17966.6Hong Kong
FL.10.2ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17966.6Hong Kong
JN.8ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17966.6Hong Kong
B.1.210ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17966.6Hong Kong
BQ.1.1.6ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17966.6Hong Kong
JN.1.56SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-17969.8Singapore
BA.4.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17982.1US
B.1.213NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17982.1US
BA.4.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17982.1US
CS.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17982.1US
XBB.1.5.46ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17986.2South Korea
B.50NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17988.2Hong Kong
B.19NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17988.2Hong Kong
JN.1.7.6NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-17999.1China
LU.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-17999.1China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used